Tuesday, May 20, 2014 9:30:41 AM
ROTH Specifics:
Product: Sucanon is quite "internet friendly". There is a ton of information and links, and it can be researched very easily.
Is it marketable? With a target market of Type II diabetes, (again, easily researched), it appears to have a broad and growing market, AND since it is not a "once and done" medication, if it shows positive results, it is a repeat seller.
People: Always have to start with CEOs, which in this case would be Luis Lopez. I haven't had much time to do a thorough background of him, so I cannot comment at this time. Also, I have a criteria of knowing what his relationship is to shareholders. Also to be investigated at a future time.
There was an announcement recently of some doctors added to the advisory board. Need to investigate them as well, not only for educational/experience background, but business savvy as well.
Processes: Still early in my DD, but it appears that several major steps have been taken to facilitate production and sales of their product, namely PNP Pharm. as manufacturer and MDR/Nadro as distributors in Mexico. (Still investigating those companies and their potentials).
Also, there has been movement under the FDA, which indicates a movement forward and a desire to expand the market, potentially in US and other countries.
Some of the other ingredients we have to mix in as investors, would include share structure/share responsibility, reporting, communications, and future growth/potential.
I could ramble on and on about specifics or details of what I look at, but to no good end. Hoping this gives you a frame of reference for what I do in my DD, and maybe it will help you with yours.
Best.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM